Condensed Consolidated Statement Of Cash Flows (USD $) In Millions	9 Months Ended
	Sep. 03, 2011	Sep. 04, 2010
Operating Activities
Net income	$ 5,060	$ 4,977
Depreciation and amortization	1,877	1,580
Stock-based compensation expense	222	191
Cash payments for restructuring charges	(1)	(29)
Merger and integration costs	174	545
Cash payments for merger and integration costs	(293)	(272)
Gain on previously held equity interests in The Pepsi Bottling Group, Inc. (PBG) and PepsiAmericas, Inc. (PAS)		(958)
Asset write-off		145
Non-cash foreign exchange loss related to Venezuela devaluation		120
Excess tax benefits from share-based payment arrangements	(56)	(73)
Pension and retiree medical plan contributions	(185)	(1,350)
Pension and retiree medical plan expenses	389	310
Bottling equity income, net of dividends		37
Deferred income taxes and other tax charges and credits	132	291
Change in accounts and notes receivable	(1,643)	(1,287)
Change in inventories	(466)	224
Change in prepaid expenses and other current assets	(54)	(14)
Change in accounts payable and other current liabilities	142	762
Change in income taxes payable	936	787
Other, net	(400)	(198)
Net Cash Provided by Operating Activities	5,834	5,788
Investing Activities
Capital spending	(1,962)	(1,670)
Sales of property, plant and equipment	46	55
Acquisition of manufacturing and distribution rights from Dr Pepper Snapple Group, Inc. (DPSG)		(900)
Investment in WBD	(164)
Other acquisitions and investments in noncontrolled affiliates	(160)	(36)
Divestitures	10
Cash restricted for pending acquisitions		(8)
Short-term investments, by original maturity
More than three months - purchases		(8)
More than three months - maturities	14	21
Three months or less, net	(48)	(53)
Other investing, net	(3)	(12)
Net Cash Used for Investing Activities	(4,695)	(5,444)
Financing Activities
Proceeds from issuances of long-term debt	3,000	4,215
Payments of long-term debt	(1,596)	(73)
Debt repurchase	(771)
Short-term borrowings, by original maturity
More than three months - proceeds	224	55
More than three months - payments	(274)	(27)
Three months or less, net	106	3,351
Cash dividends paid	(2,349)	(2,218)
Share repurchases - common	(1,929)	(4,418)
Share repurchases - preferred	(5)	(3)
Proceeds from exercises of stock options	724	700
Excess tax benefits from share-based payment arrangements	56	73
Acquisition of noncontrolling interests	(1,327)	(159)
Other financing	(2)	(6)
Net Cash (Used for)/Provided by Financing Activities	(4,143)	1,490
Effect of exchange rate changes on cash and cash equivalents	144	(200)
Net (Decrease)/Increase in Cash and Cash Equivalents	(2,860)	1,634
Cash and Cash Equivalents, Beginning of Year	5,943	3,943
Cash and Cash Equivalents, End of Period	3,083	5,577
Non-cash activity:
Issuance of common stock and equity awards in connection with our acquisitions of PBG and PAS, as reflected in investing and financing activities		$ 4,451